Adjunctive treatment of acute mania with risperidone versus typical antipsychotics: A retrospective study

Kaohsiung Journal of Medical Sciences

Volumn 21, Issue 12, 2005, Pages 539-544

  Tsai, Jui Hsiu ^a   Tang, Tze Chun ^b   Yang, Pinchen ^b   Yen, Cheng Fang ^b   Yang, Ming Jen ^b   Yen, Ju Yu ^a   Chen, Cheng Chung ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Tsyr Huey (Loving) Mental Hospital   (Taiwan)

Author keywords

Anticholinergics; Bipolar I disorder; Risperidone; Trihexyphenidyl

Indexed keywords

CHLORPROMAZINE; CLOTIAPINE; HALOPERIDOL; MOOD STABILIZER; NEUROLEPTIC AGENT; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TRIHEXYPHENIDYL;

ADULT; AGE DISTRIBUTION; ARTICLE; BIPOLAR I DISORDER; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MANIA; OUTCOME ASSESSMENT; SEX RATIO; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 29544450225     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1607-551x(09)70205-0     Document Type: Article

References (27)

1. Regier DA, Myers JK, Kramer M, et al. The NIMH epidemiologic catchment area program: historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 1984;41:934-41.
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
3. Tohen M, Goodwin FK. Epidemiology of bipolar disorder. In: Tsuang MT, Tohen M, Zahner G, eds. Psychiatric Epidemiology. New York: John Wiley & Sons, 1995:301-16.
4. Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salt. J Neurol Neurosurg Psychiatry 1954;17:250-60.
5. Goodwin FK, Murphy DL, Bunney WE. Lithium carbonate treatment in depression and mania: a longitudinal double-blind study. Arch Gen Psychiatry 1969;21:486-96.
6. Prien RF, Caffey EM, Klett CJ. A comparison of lithium carbonate and chlorpromazine in the treatment of acute mania. Arch Gen Psychiatry 1972;26:146-53.
7. Takahashi R, Sakuma A, Itoh K, et al. Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Arch Gen Psychiatry 1975;32:1310-8.
8. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994;151:1-36.
9. Freeman MP, Stoll AL. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 1998;155:12-21.
10. th edition. Philadelphia: Lippincott Williams & Wilkins, 2003:570-1.
11. Bodkin JA. Emerging uses for high-potency benzodiazepines in psychotic disorders. J Clin Psychiatry 1990;51:41-6.
12. Lenox RH, Newhouse PA, Creelman WL, Whitaker TM. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. J Clin Psychiatry 1992;53: 47-52.
13. Sernyak MJ, Griffin RA, Johnson RM, et al. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994;151:133-5.
14. Keck PE, McElroy SL, Strakowski SM, et al. Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. J Clin Psychiatry 1996;57:147-51.
15. Zarate CA, Tohen M. Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. J Clin Psychiatry 2000;61:33-8.
16. Kukopulos A, Reginadi D, Laddomada P, et al. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol 1980;13:156-67.
17. Kane JM, Jeste DV, Barnes TRE, et al. Tardive Dyskinesia: a Task Force Report of the American Psychiatric Association. Washington, DC: American Psychiatric Press, 1992.
18. Ghaemi SN, Goodwin FK. Use of atypical agents in bipolar and schizoaffective disorders: review of the empirical literature. J Clin Psychiatry 1999;19:354-61.
19. Miller DS, Yatham LN, Lam RW. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. J Clin Psychiatry 2001;62:975-80.
20. Alder L, Ulrich M, Lehmann K, et al. Acute inpatient treatment of manias. Effects of independent variables on neuroleptic dosage and length of stay. Nervenarzt 1996;67:235-43.
21. th edition. Philadelphia: Lippincott Williams & Wilkins, 2003:1050-67.
22. Luborsky L. Clinicians' judgments of mental health. Arch Gen Psychiatry 1962;7:407-17.
23. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept of Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health, 1976:218-22.
24. Bazire S. Selecting drugs, doses and preparations: switching drugs. In: Bazire S, ed. Psychotropic Drug Directory 2003/04. Salisbury: Fivepin Publishing, 2003:179-80.
25. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 1994;271:918-24.
26. Sachs GS, Grossman F, Ghaemi SN, et al. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002;159:1146-54.
27. Lane HY, Chiu WC, Chou JCY, et al. Risperidone in acute exacerbated schizophrenia: dosing strategies and plasma levels. J Clin Psychiatry 2000;61:209-14.